Abstract
High efficacy, dopamine D3 receptor‐preferring agonists, such as pramipexole, produce antidepressant‐like effects in rodents that are mediated by either a combination of the D2 and D3 receptor subtypes or the D2 receptor alone. Little is known about the antidepressant‐like effects of D2/3 receptor partial agonists; therefore, this study investigated the antidepressant‐like activity of the D3‐preferring partial agonists, BP897, CJ998, and CJ1037, and the mixed action D2 partial agonist aripiprazole in rats. We hypothesized that a D3 partial agonist alone would not be sufficient to produce antidepressant‐like effects. These compounds were evaluated alone and as pretreatments to pramipexole in the rat forced swim test. These compounds produced little, if any, antidepressant‐like activity on their own; however, BP897 and aripiprazole antagonized the antidepressant‐like effects of pramipexole. These data suggest that partial agonist activity at the dopamine D3 and/or D2 receptors is not sufficient to produce antidepressant‐like activity and that partial agonists can block the actions of high efficacy agonists, consistent with receptor theory. Overall, these findings further demonstrate that activation of D2 and D3 receptors with high efficacy agonists is required to produce antidepressant‐like effects in rodents. This work was supported in part by USPHS grants DA020669 and T32 DA07268.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.